ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation.
Link F, Li Y, Zhao J, Munker S, Fan W, Nwosu ZC, Yao Y, Wang S, Huang C, Liebe R, Hammad S, Liu H, Shao C, Gao C, Sun B, Török NJ, Ding H, Ebert MP, Weng H, Ten Dijke P, Drasdo D, Dooley S, Wang S.
Link F, et al. Among authors: dooley s.
Gut. 2024 Oct 24:gutjnl-2024-333213. doi: 10.1136/gutjnl-2024-333213. Online ahead of print.
Gut. 2024.
PMID: 39448254